NRSN Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Neurosense Therapeutics Ltd (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.0276, suggesting NRSN is Strong Sell.

Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.782, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it Sell.

Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.78, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it Sell.

Technical Analysis for NRSN

Technical Sentiment Analysis for Neurosense Therapeutics Ltd (NRSN) As of 2026-06-16, Neurosense Therapeutics Ltd (NRSN) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 14 technical signals, shows that 5 indicators are flashing buy, while 9 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NRSN stands at 36.55, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0276, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 9.692 and the Commodity Channel Index (CCI) at -145.276 further confirm a -0.101 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NRSN is trading below its 60-day moving average of $0.78 and below its 200-day long-term moving average of $0.948. Key price levels to watch include the immediate resistance at $0.831 and strong support at $0.661. A break above $0.831 could signal a bull continuation, while falling below $0.661 may test the next Fibonacci floor at $0.581.

Neurosense Therapeutics Ltd (NRSN) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.491	0.581	0.661	0.75	0.831	0.92	1.001
Fibonacci	0.581	0.646	0.686	0.75	0.815	0.855	0.92

Neurosense Therapeutics Ltd (NRSN) Technical Indicators

2026-06-16

Name	Value
RSI_14	36.55
STOCHk_14_3_3	9.692
STOCHd_14_3_3	9.967
CCI_20	-145.276
AO_5_34	-0.0912
MOM_10	-0.101
MACD_12_26_9	-0.0276

Neurosense Therapeutics Ltd (NRSN) Relative Strength Index (RSI) is 36.55, creating a Neutral signal.

Neurosense Therapeutics Ltd (NRSN) Stochastic Oscillator is 9.692, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Stochastic RSI is 9.967, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Commodity Channel Index (CCI) is -145.276, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Awesome Oscillator is -0.0912, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) Momentum is -0.101, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) MACD is -0.0276, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) Moving Average

2026-06-16

Period	Simple	Signal
MA_5	0.718	Sell
MA_10	0.741	Sell
MA_20	0.782	Sell
MA_60	0.78	Sell
MA_200	0.948	Sell
MA_250	1.097	Sell

Neurosense Therapeutics Ltd (NRSN) 5-Day simple moving average is 0.718, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 10-Day simple moving average is 0.741, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.782, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.78, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 200-Day simple moving average is 0.948, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 250-Day simple moving average is 1.097, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NRSN?

The overall technical consensus for Neurosense Therapeutics Ltd (NRSN) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 5 buy signals and 3 sell signals.

What are the key support and resistance levels for Neurosense Therapeutics Ltd (NRSN) today?

Based on pivot point calculations, Neurosense Therapeutics Ltd (NRSN) has an immediate support level at 0.661 and a major resistance level at 0.831. Traders also monitor the pivot point at 0.75 to determine the intraday trend direction.

Is Neurosense Therapeutics Ltd (NRSN) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Neurosense Therapeutics Ltd (NRSN) is currently 36.55. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Neurosense Therapeutics Ltd (NRSN)?

Neurosense Therapeutics Ltd (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.0276, suggesting NRSN is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Neurosense Therapeutics Ltd.

How is Neurosense Therapeutics Ltd (NRSN) performing relative to its 200-day moving average?

Neurosense Therapeutics Ltd (NRSN) is currently trading at $0.699, which is below its 200-day simple moving average of 0.948. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.